Odimma

MABDESIGN MEMBER

About us

Odimma has for mission to bring a sustainable diagnostic and therapeutic solution in oncology adapted to each patient.

Know-how

Vaccins, Neoantigenes, Personalised Immunotherapy, Oncology

Business offer

The product to be developed by Odimma is an active personalised immunotherapeutic formulation based on recent advances in cancer genomics and immunotherapy.

Field of application
  • therapeutic vaccines
Therapeutic application
  • oncology

Expertise

  • Expression and pathway analysis of target
  • quantification of target
  • Assay development in in-vitro & in-vivo models
  • Research exploratory companion biomarkers
  • Formulation
  • Dose
  • Adjuvants
  • Delivery
  • Route of Administration
  • Phase I

Category

  • Therapeutic product

Contact